Beam Therapeutics (BEAM) was a big mover last session on higher-than-average trading volume. The latest trend in earnings ...

The KIMS Cancer Centre has successfully treated a patient suffering from Cutaneous T-cell Lymphoma using Electron Beam Therapy (EBT), a specialized radiation technique designed to precisely target ...

Amarna Therapeutics and NorthX Biologics finalized an agreement to advance Nimvec AM510 gene therapy toward clinical trials for Type 1 Diabetes. Now in its fourth year, the MM+M Media Summit brings ...

Beam Therapeutics Inc. research and ratings by Barron's. View BEAM revenue estimates and earnings estimates, as well as in-depth analyst breakdowns.

A radio presenter left partially sighted by a rare eye cancer is set to start Worcester's Race for Life. Julian Wharam, broadcaster and teacher, was diagnosed with choroidal melanoma after seeing ...

Marking a milestone in precision oncology, Concord treats a rare choroidal melanoma case with cutting-edge proton therapy.

Sana Biotechnology, Inc. (NASDAQ:SANA) is among the fundamentally strong penny stocks to invest in. Morgan Stanley has ...

With half a million people having already received multi-cancer early detection (MCED) screening, patients are and will continue to be asking about these blood tests during their visits, physicians ...

Armed with new proof-of-concept data showing that its in vivo base-editing therapy BEAM-302 can correct the gene mutation in alpha-1 antitrypsin deficiency (AATD), Beam Therapeutics is seeking to ...

GT Medical Technologies announced today that it completed the close of its oversubscribed $53 million Series D equity financing.

After the emotional shock of a breast cancer recurrence, Teah decided to seek care – and proton therapy – at Fred Hutch ...